183 related articles for article (PubMed ID: 24680888)
1. Antisense oligonucleotide-based therapy in human erythropoietic protoporphyria.
Oustric V; Manceau H; Ducamp S; Soaid R; Karim Z; Schmitt C; Mirmiran A; Peoc'h K; Grandchamp B; Beaumont C; Lyoumi S; Moreau-Gaudry F; Guyonnet-Dupérat V; de Verneuil H; Marie J; Puy H; Deybach JC; Gouya L
Am J Hum Genet; 2014 Apr; 94(4):611-7. PubMed ID: 24680888
[TBL] [Abstract][Full Text] [Related]
2. Erythroid-Progenitor-Targeted Gene Therapy Using Bifunctional TFR1 Ligand-Peptides in Human Erythropoietic Protoporphyria.
Mirmiran A; Schmitt C; Lefebvre T; Manceau H; Daher R; Oustric V; Poli A; Lacapère JJ; Moulouel B; Puy H; Karim Z; Peoc'h K; Lenglet H; Simonin S; Deybach JC; Nicolas G; Gouya L
Am J Hum Genet; 2019 Feb; 104(2):341-347. PubMed ID: 30712775
[TBL] [Abstract][Full Text] [Related]
3. Modeling the ferrochelatase c.315-48C modifier mutation for erythropoietic protoporphyria (EPP) in mice.
Barman-Aksözen J; C Wiek P; Bansode VB; Koentgen F; Trüb J; Pelczar P; Cinelli P; Schneider-Yin X; Schümperli D; Minder EI
Dis Model Mech; 2017 Mar; 10(3):225-233. PubMed ID: 28093505
[TBL] [Abstract][Full Text] [Related]
4. A Novel Mutation in the FECH Gene in a Czech Family with Erythropoietic Protoporphyria and a Population Study of IVS3-48C Variant Contributing to the Disease.
Farrag MS; Kučerová J; Šlachtová L; Šeda O; Šperl J; Martásek P
Folia Biol (Praha); 2015; 61(6):227-32. PubMed ID: 26789144
[TBL] [Abstract][Full Text] [Related]
5. A novel splicing mutation and haplotype analysis of the FECH gene in a Chinese family with erythropoietic protoporphyria.
Ma J; Xiao S; An J; Wang X; Xu Q; Dong Y; Feng Y; Wang J
J Eur Acad Dermatol Venereol; 2010 Jun; 24(6):726-9. PubMed ID: 19888946
[TBL] [Abstract][Full Text] [Related]
6. Biochemical abnormality in erythropoietic protoporphyria: cause and consequences.
Bloomer JR; Wang Y; Singhal A; Risheg H
J Pediatr Gastroenterol Nutr; 2006 Jul; 43 Suppl 1():S36-40. PubMed ID: 16819399
[TBL] [Abstract][Full Text] [Related]
7. [Inheritance in erythropoietic protoporphyria].
Schmitt C; Ducamp S; Gouya L; Deybach JC; Puy H
Pathol Biol (Paris); 2010 Oct; 58(5):372-80. PubMed ID: 20850938
[TBL] [Abstract][Full Text] [Related]
8. Iron availability modulates aberrant splicing of ferrochelatase through the iron- and 2-oxoglutarate dependent dioxygenase Jmjd6 and U2AF(65.).
Barman-Aksözen J; Béguin C; Dogar AM; Schneider-Yin X; Minder EI
Blood Cells Mol Dis; 2013 Oct; 51(3):151-61. PubMed ID: 23787363
[TBL] [Abstract][Full Text] [Related]
9. Digital PCR (dPCR) analysis reveals that the homozygous c.315-48T>C variant in the FECH gene might cause erythropoietic protoporphyria (EPP).
Brancaleoni V; Granata F; Missineo P; Fustinoni S; Graziadei G; Di Pierro E
Mol Genet Metab; 2018 Aug; 124(4):287-296. PubMed ID: 29941360
[TBL] [Abstract][Full Text] [Related]
10. Delivery of oligonucleotides to bone marrow to modulate ferrochelatase splicing in a mouse model of erythropoietic protoporphyria.
Halloy F; Iyer PS; Ćwiek P; Ghidini A; Barman-Aksözen J; Wildner-Verhey van Wijk N; Theocharides APA; Minder EI; Schneider-Yin X; Schümperli D; Hall J
Nucleic Acids Res; 2020 May; 48(9):4658-4671. PubMed ID: 32313951
[TBL] [Abstract][Full Text] [Related]
11. Biochemical and molecular diagnosis of erythropoietic protoporphyria in an Ashkenazi Jewish family.
Schneider-Yin X; Mamet R; Minder EI; Schoenfeld N
J Inherit Metab Dis; 2008 Dec; 31 Suppl 2():S363-7. PubMed ID: 18758989
[TBL] [Abstract][Full Text] [Related]
12. Incomplete erythropoietic protoporphyria caused by a splice site modulator homozygous IVS3-48C polymorphism in the ferrochelatase gene.
Mizawa M; Makino T; Nakano H; Sawamura D; Shimizu T
Br J Dermatol; 2016 Jan; 174(1):172-5. PubMed ID: 26280465
[TBL] [Abstract][Full Text] [Related]
13. Novel mutations and phenotypic effect of the splice site modulator IVS3-48C in nine Swedish families with erythropoietic protoporphyria.
Wiman A; Floderus Y; Harper P
J Hum Genet; 2003; 48(2):70-6. PubMed ID: 12601550
[TBL] [Abstract][Full Text] [Related]
14. Erythropoietic protoporphyria.
Lecha M; Puy H; Deybach JC
Orphanet J Rare Dis; 2009 Sep; 4():19. PubMed ID: 19744342
[TBL] [Abstract][Full Text] [Related]
15. Molecular characterization of erythropoietic protoporphyria in South Africa.
Parker M; Corrigall AV; Hift RJ; Meissner PN
Br J Dermatol; 2008 Jul; 159(1):182-91. PubMed ID: 18460026
[TBL] [Abstract][Full Text] [Related]
16. Contribution of a common single-nucleotide polymorphism to the genetic predisposition for erythropoietic protoporphyria.
Gouya L; Martin-Schmitt C; Robreau AM; Austerlitz F; Da Silva V; Brun P; Simonin S; Lyoumi S; Grandchamp B; Beaumont C; Puy H; Deybach JC
Am J Hum Genet; 2006 Jan; 78(1):2-14. PubMed ID: 16385445
[TBL] [Abstract][Full Text] [Related]
17. Inheritance in erythropoietic protoporphyria: a common wild-type ferrochelatase allelic variant with low expression accounts for clinical manifestation.
Gouya L; Puy H; Lamoril J; Da Silva V; Grandchamp B; Nordmann Y; Deybach JC
Blood; 1999 Mar; 93(6):2105-10. PubMed ID: 10068685
[TBL] [Abstract][Full Text] [Related]
18. Genotypic determinants of phenotype in North American patients with erythropoietic protoporphyria.
Risheg H; Chen FP; Bloomer JR
Mol Genet Metab; 2003; 80(1-2):196-206. PubMed ID: 14567969
[TBL] [Abstract][Full Text] [Related]
19. Hypermethylation of the wild-type ferrochelatase allele is closely associated with severe liver complication in a family with erythropoietic protoporphyria.
Onaga Y; Ido A; Uto H; Hasuike S; Kusumoto K; Moriuchi A; Numata M; Nagata K; Hori T; Hayashi K; Tsubouchi H
Biochem Biophys Res Commun; 2004 Sep; 321(4):851-8. PubMed ID: 15358105
[TBL] [Abstract][Full Text] [Related]
20. The molecular genetics of erythropoietic protoporphyria.
Elder GH; Gouya L; Whatley SD; Puy H; Badminton MN; Deybach JC
Cell Mol Biol (Noisy-le-grand); 2009 Jul; 55(2):118-26. PubMed ID: 19656460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
